Multicentered Canadian experience with long-term oral sitaxsentan in pulmonary arterial hypertension

被引：0
|
作者：
Al-Harbi, Abdullah [1 ]
Granton, John T. [1 ]
Helmersen, Doug [1 ]
Langleben, David [1 ]
Levy, Robert D. [1 ]
Provencher, Steeve [1 ]
Mehta, Sanjay [1 ]
机构：
[1] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：632S / 633S
页数：2
相关论文
共 50 条
  • [31] Is sitaxsentan a safe and efficacious treatment for pulmonary arterial hypertension?
    Marius M Hoeper
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 536 - 537
  • [32] Is sitaxsentan a safe and efficacious treatment for pulmonary arterial hypertension?
    Hoeper, Marius M.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (10): : 536 - 537
  • [33] Long-term Effects of Epoprostenol on the Pulmonary Vasculature in Idiopathic Pulmonary Arterial Hypertension
    Rich, Stuart
    Pogoriler, Jennifer
    Husain, Aliya N.
    Toth, Peter T.
    Gomberg-Maitland, Mardi
    Archer, Stephen L.
    CHEST, 2010, 138 (05) : 1234 - 1239
  • [34] Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension
    Onen, Zeynep Pinar
    Yildiz, Onur Akkoca
    Gulbay, Banu Eris
    Karabiyikoglu, Gulseren
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2006, 54 (02): : 177 - 181
  • [35] Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    Stiebellehner, L
    Petkov, V
    Vonbank, K
    Funk, G
    Schenk, P
    Ziesche, R
    Block, LH
    CHEST, 2003, 123 (04) : 1293 - 1295
  • [36] Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue
    Vizza, CD
    Sciomer, S
    Morelli, S
    Lavalle, C
    Di Marzio, P
    Padovani, D
    Badagliacca, R
    Vestri, AR
    Naeije, R
    Fedele, F
    HEART, 2001, 86 (06) : 661 - 665
  • [37] Impact of transition from Sitaxsentan to Ambrisentan in Pulmonary Arterial Hypertension
    Safdar, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [38] Long-term inhaled iloprost use in children with pulmonary arterial hypertension
    Alehan, Dursun
    Yildirim, Isil
    Sahin, Murat
    Ozkutlu, Suheyla
    Ozer, Sema
    Karagoz, Tevfik
    CARDIOLOGY IN THE YOUNG, 2012, 22 (04) : 396 - 403
  • [39] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [40] Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
    Ben-Yehuda, Ori
    Pizzuti, David
    Brown, Andrea
    Littman, Marcus
    Gillies, Hunter
    Henig, Noreen
    Peschel, Tobias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) : 80 - U105
12345